Neuberg A. G Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.05 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.00 Cr
as on 16-11-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 26.94%
(FY 2023)
- Profit -5.84%
(FY 2023)
- Ebitda 6.39%
(FY 2023)
- Net Worth -993.66%
(FY 2023)
- Total Assets 53.70%
(FY 2023)
About Neuberg A. G Diagnostics
The Corporate was formerly known as Neuberg Wellspring Oncopath Labs Private Limited. The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.05 Cr and a paid-up capital of Rs 4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aishwarya Sundeep and Kavya Velu serve as directors at the Company.
- CIN/LLPIN
U85100MH2018PTC313967
- Company No.
313967
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neuberg A. G Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aishwarya Sundeep  | Nominee Director | 06-May-2021 | Current |
| Kavya Velu | Director | 10-Jun-2024 | Current |
Financial Performance of Neuberg A. G Diagnostics.
Neuberg A. G Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.94% increase. The company also saw a slight decrease in profitability, with a 5.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 993.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg A. G Diagnostics?
In 2023, Neuberg A. G Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_303771.webp)
Neuberg Ajay Shah Laboratory Private LimitedActive 4 years 6 monthsAishwarya Sundeep is a mutual person
Neuberg Sehgal Path Lab Private LimitedActive 3 years 3 monthsAishwarya Sundeep and Kavya Velu are mutual person
- Neuberg Sai Sridevi Diagnostics Private LimitedActive 3 years 2 months
Aishwarya Sundeep is a mutual person
- Avishkar Diagnostics (W.B.) Private LimitedActive 11 months 1 day
Aishwarya Sundeep is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neuberg A. G Diagnostics?
Neuberg A. G Diagnostics has a workforce of 55 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg A. G Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg A. G Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
